BackImmunogen Overview

Immunogen Total Assets

Track Immunogen's total assets ($820M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$822.10M
↑ 129.13% YoYΔ $463.30M vs prior year quarter

Peer average

Loading

Immunogen Total Assets History

Loading

Immunogen vs. peers: Total Assets Comparison

Loading

Immunogen Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immunogen (IMGN) FAQ

As of the most recent data (September 2023), IMGN shows a total assets of $820M. That compares with $360M in the prior-year period — up 129.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMGN's total assets is now $820M (was $360M) — a 129.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immunogen is outperforming or lagging.

Tracking IMGN's total assets over time shows whether Immunogen is scaling, shrinking, or reshaping that part of the business. The current reading is $820M That compares with $360M in the prior-year period — up 129.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Immunogen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $820M) with ownership activity and broader fundamentals.

Immunogen's total assets is $820M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.